ICU Medical operates through three primary business segments: Consumables, Infusion Systems, and Vital Care. The Consumables segment provides IV therapy and oncology products, including the widely used Clave family of needlefree connectors and ChemoLock closed system transfer devices. The Infusion Systems segment offers IV smart pumps, dedicated disposable sets, and the ICU Medical MedNet medication management software. The Vital Care segment focuses on hemodynamic monitoring systems, respiratory support, and related critical care products. The company significantly expanded its global footprint and product portfolio through the acquisitions of Pfizer's Hospira Infusion Systems business in 2017 and Smiths Medical in 2022. ICU Medical maintains a global manufacturing presence with key facilities in the United States, Mexico, and Slovakia.
